激素吸入疗法治疗及干预毛细支气管炎的疗效观察被引量：17

Investigation on the effect of glucocorticoid inhalation on treating and interfering of bronchiolitis.

导出

摘要【目的】观察激素吸入疗法对毛细支气管炎(简称毛支炎)治疗效果以及减少毛支炎后哮喘发病情况,为临床治疗提供依据。【方法】89例毛支炎患儿在发病期分别给于布地奈德、硫酸沙丁胺醇雾化吸入及传统的治疗,对照观察其疗效;选择部分患儿于毛支炎痊愈后继续吸入一定时期的普米克气雾剂进行干预治疗,观察2年内哮喘的发病情况。【结果】吸入组毛支炎病情恢复明显快于对照组;干预组哮喘发病率明显低于对照组(P<0.05)。【结论】激素吸入疗法可提高毛支炎疗效,且长期吸入可降低哮喘的发病率。 [Objectives] To investigate the effect of inhaling steroids on treating bronchiolitis and decreasing the incidence of asthma after hronchiolitis. [Methods] 89 infants with acute hronchiolitis were observed comparatively with inhaling bonidudese and salbutamol or traditional therapeutics. Meanwhile compare the incidence of asthma in children with bronehiolitis had been or not been inhaled Pulmicort some periods after clinical remission. [Results] The recovery of inhaling group was significantly faster than control group, and the incidence of asthma in inhaling group was significantly lower than thai in control group （P〈0.05）. [Conclusion] Inhaling steroids can improve the treatment of bronchiolitis obviously, and long-term inhalation of steroids can prevent recurrent wheezing.

作者王峻曹永利毕玫荣

机构地区山东大学中心医院儿科

出处《中国儿童保健杂志》 CAS 2006年第1期51-52,共2页 Chinese Journal of Child Health Care

关键词毛细支气管炎哮喘吸入布地奈德发病率 bronchiolitis asthma inhalation honidudese incidence

分类号 R722.1 [医药卫生—儿科]

引文网络
相关文献

参考文献5

1胡亚美江载方.实用儿科学[M](第7版)[M].北京:人民卫生出版社,2002.655.
2TURKTAS I,OZKAYA O,BOSTANCI I,et al.Safety of inhaled corticosteroid therapy in young children with asthma[J].Am Allergy Asthma Immunol,2001,86:649-654.
3陈坤华.毛细支气管炎后吸入激素干预治疗与哮喘相关研究[J].临床儿科杂志,2003,21(8):506-507. 被引量：129
4BEHZMAN RE,KILEGMAN RM,ARVIN AM,et al.Nelson Textbook of Pediatrics[M].16th ed.Philadelphia:WB Saunders Co.2000:1285-1287.
5UMETSU DT,MCLNTIRE J,AKBARI O,et al.Asthma:an epidemic of dysregulated imrmunity[J].Nature Immunol,2002,3:715-719.

二级参考文献12

1Behzman RE, Kilegman RM, Arvin AM, et al. Nelson Textbook of Pediatrics, 16th ed. Philadelphia: WB Saunders Co, 2000 : 1285- 1287.
2Martinez FD, Stern DA, Wright AL, et al. Differential immune responses to acute lower respiratory illness in early life by subsequent development of persistent wheezing and asthma. J Allergy Clin Immunol, 1998, 102 : 915- 920.
3Bisgaard H, Mauck SL, Nielsen JP, et al. Inhaled badesonide for treatment of recurrent wheezing in early childhood. Lancet,1990, 336 : 649 - 651.
4Wamer JA. Primary sensitization in infants.Ann Allergy Asthma Immunol, 1999, 83 : 426 - 429.
5Tovey E, Marks G. Methods and effectiveness of environmental control.J Allergy Clin Immunol, 1999, 103 : 179- 191.
6Parmonchi PA, Bauguolo F, Sampognaro S, et al. Genetic and environmental factors contributing to the onset of allergic disorders. Int Arch Allergy Immunol, 2000, 121 : 2- 9.
7Gustafsson P, Tsanalas J, Gold M, et al. Comparison of the efficacy and safety of inhaled fluticasone propionate 200 micrograms/ day with inhaled beclomethasone dipropionate 400 micrograms/ day in mild and moderate asthma. Arch Dis Child,1993, 69 : 206 - 211.
8Turktas I, Ozkaya O, Bostanci I, et al. Safety of inhaled corticosteroid therapy in young children with asthma. Ann Allergy Asthma Immunol, 2001 Jun, 86(6) : 649- 654.
9Lonky SA, Tis GM. Determinging changes in airway caliber in asthma: The role of submaximal expiratory flow rate. Chest, 1980,77(6) : 741-744.
10Erb KJ, Holloway JW, Sobeck A, et al. Infection of mice with Mycobacterium bovis-Bacillus Calmette-Guerin(BCG) suppresses allergen-induced airway eosinophilia.J Exp Med,1998, 4 : 561 - 569.